Hemorrhagic Diathesis

(redirected from Bleeding diathesis)
Also found in: Medical, Wikipedia.

hemorrhagic diathesis

[‚hem·ə′raj·ik dī′ath·ə·səs]
(medicine)
Any condition marked by abnormal bleeding tendency.

Hemorrhagic Diathesis

 

a predisposition to bleeding. Hemorrhagic diathesis may be manifested as an independent disease, associated with an impairment of blood coagulability, or as a secondary symptom of a variety of infectious diseases, avitaminoses, (for example, scurvy), and severe kidney lesions.

References in periodicals archive ?
Out of 6 patients with bleeding diathesis, majority (50%) belongs to 5-10 years.
Patients with bleeding diathesis were not included in this study.
Hermansky-Pudlak syndrome subtype 5 (HPS-5) novel mutation in a 65 year-old with oculocutaneous hypopigmentation and mild bleeding diathesis: the importance of recognizing a subtle phenotype.
During his follow-up one year after the episode as an outpatient in our clinic, he had a complete recovery without any other reported episodes of bleeding diathesis. Clotting assays remain between normal ranges.
Factor V (Quebec): a bleeding diathesis associated with a qualitative platelet factor V deficiency.
Patients with liver cirrhosis, uncontrolled diabetes mellitus, accompanying perianal disease, inflammatory bowel disease, pregnancy, or bleeding diathesis were excluded from the study.
The family history of tuberculosis, bleeding diathesis, and thyroid disorder was noted.
He also mentioned about absolute and relative contraindications to Aspirin therapy like hypersensitivity to Aspirin, bleeding diathesis, active peptic ulcer and pregnant women after 36 weeks of pregnancy.
Methods: The patients who only underwent coronary artery bypass surgery for the first time in the past three years and did not have any bleeding diathesis were retrospectively analyzed from the cardiac surgery database of CPEIC Multan.
However, the nasal route is contraindicated in patients with intranasal pathology, bleeding diathesis, and basal skull fractures.
Patients with cardiogenic shock, intra-aortic balloon pump, serum creatinine >2.5 mg/dl, hemoglobin (Hb) <9 g/dl, and bleeding diathesis were excluded from the study.
The present purchase is made as part of the health program of the Minister of Health under the name "National Programme for Treatment of Hemophilia and Related bleeding diathesis for the years 2012-2018."